Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

New drug delivery methods can make natural compounds more effective and stable.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Better supportive care is needed to manage chemotherapy side effects.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The treatment combination is effective and generally safe for lung cancer.

Growth factors are crucial for hair development and could help treat hair diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Adding a second method to PROTACs could improve cancer treatment.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.